Cavelier B, Daveau M, Gilbert D, Fontaine M, Cesarini J P, Delpech B
C R Seances Acad Sci D. 1980 Sep 15;291(2):241-3.
HLA-A and B phenotypes of 105 patients suffering from malignant melanomas were determined, with special regard for metastatic form or relapse. A highly significant increase of the HLA-A9 antigen is seen (X2 = 17.47); such data had already been shown by van Wijek [2], but other authors did not find this abnormality when studying melanomas whose histologic form was not specified.